Literature DB >> 4563156

A controlled study of prindolol (Visken) in hypertension.

P Thorpe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4563156     DOI: 10.5694/j.1326-5377.1972.tb47305.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

Review 2.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

3.  Effect of propranolol on the blood pressure of normotensive and pinealectomized hypertensive rats.

Authors:  H Karppanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 4.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.

Authors:  R E Buckingham; T C Hamilton; D Robson
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

6.  [Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].

Authors:  K Undeutsch; H G Sieberth; K A Meurer
Journal:  Klin Wochenschr       Date:  1976-11-15

Review 7.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.